STOCK TITAN

NewGenIvf (NIVF) director Tam Chun Wa submits initial Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

NewGenIvf Group Ltd director Tam Chun Wa submitted an initial ownership report on Form 3. The filing lists Tam Chun Wa as a director of the company but does not report any share purchases, sales, or other insider transactions.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Tam Chun Wa

(Last)(First)(Middle)
48NA, TOWER 1, PHASE 1
FESTIVAL CITY, TAI WAI

(Street)
HONG KONG

(City)(State)(Zip)

CHINA

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
This Form 3 is being filed after the March 18, 2026 deadline due to delay in issuance of EDGAR access codes following timely submission of the Form ID application on March 11, 2026. The filing is made promptly upon receipt of the access codes.
No securities are beneficially owned.
/s/ Chun Wa Tam03/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NewGenIvf (NIVF) Form 3 filing by Tam Chun Wa show?

The Form 3 shows that Tam Chun Wa is a director of NewGenIvf Group Ltd. It is an initial ownership report and, in this case, does not list any insider share purchases, sales, or other transactions.

Does the NIVF Form 3 for Tam Chun Wa report any share purchases or sales?

No, the Form 3 for Tam Chun Wa reports no insider share purchases or sales. The transaction summary shows zero buy, sell, acquire, dispose, exercise, gift, tax withholding, or restructuring transactions.

What insider role does Tam Chun Wa have at NewGenIvf Group Ltd (NIVF)?

Tam Chun Wa is reported as a director of NewGenIvf Group Ltd. The Form 3 flags the reporting person as a director, with no officer role or ten percent owner status indicated in the filing data.

Are there any derivative securities reported in the NIVF Form 3 for Tam Chun Wa?

No derivative securities are reported for Tam Chun Wa in this Form 3. The derivative summary is empty, and the filing shows no option exercises, conversions, or other derivative transactions or holdings.

What is the overall transaction activity in the NewGenIvf (NIVF) Form 3?

The Form 3 shows no transaction activity. All transaction counts and share amounts for buys, sells, exercises, gifts, tax withholding, and restructuring are zero, indicating only an initial status report for the director.
NewGenIvf Group

NASDAQ:NIVF

View NIVF Stock Overview

NIVF Rankings

NIVF Latest News

NIVF Latest SEC Filings

NIVF Stock Data

1.17M
568.27k
Medical Care Facilities
Healthcare
Link
Thailand
Bangkok